CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9,573 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02316678
NCT02316678N/ACompleted
CompareCT.gov

Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics

University of Pennsylvania·observational·Posted Dec 15, 2014·Updated May 19, 2017

In Brief

An observational study evaluating No intervention for Colitis, Ulcerative and 2 related conditions. Completed, enrolled 9,573 participants across 1 site.

Detailed Summary

The investigators will test the hypothesis that that greater efficacy of anti-tumor necrosis factor (antiTNF) therapy results in reduced need for bowel resection surgery, fewer serious infections, and reduced short term mortality risks, and therefore has a more favorable benefit to harm profile than corticosteroids for inflammatory bowel disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColitis, Ulcerative, Inflammatory Bowel Diseases, Crohn's Disease
CountriesUnited States
CollaboratorsCrohn's and Colitis Foundation, University of Alabama at Birmingham, Duke University, Patient-Centered Outcomes Research Institute

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 15, 2014
Enrollment StartSep 1, 2014
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.5 years ago

Interventions

No interventionother

There is no intervention